Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 661, pseudogene (RNU6-661P) is a DNA sequence in the human genome closely related to the U6 small nuclear RNA (snRNA) gene family, sharing high sequence homology but lacking protein-coding potential and canonical RNA function due to mutations or truncations. U6 snRNA itself is highly conserved, provides core catalytic functions in the spliceosome for intron removal from pre-mRNA, and is transcribed by RNA polymerase III[1][2]. Many vertebrate genomes contain pseudogenes derived from U6 snRNA, such as RNU6-661P, but these serve mainly as evolutionary relics of gene duplication or retrotransposition events and are typically not functionally expressed nor catalytically active[2][3]. There is no evidence that RNU6-661P, as a pseudogene, plays an active role in human disease, drug response, or cellular physiology[3][4]. RNU6-661P is best classified as a non-coding RNA pseudogene and not as a functional therapeutic target, biomarker, or druggable entity. If functional investigation is required, canonical U6 snRNA (not pseudogenes) should be referenced for splicing and molecular function[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 661, pseudogene (RNU6-661P).